- Raised $30M funding round, Mar 2025
- Raised $6M funding round led by Almeda Ventures, Nov 2020
- Raised $2.7M grant, Jul 2024
About
Nurami harnesses nanofibers and novel biomaterials to modernize soft tissue surgical repair. Nurami’s proprietary, electrospun-based platform technology enables the creation of an innovative category of bio surgical implants to seal and heal wounds effectively. These advanced products address complications associated with current soft tissue implants, such as dangerous leaks, and promote healthy tissue formation such as Dura repair as well as other tissue recovery processes.
Nurami's first soft-tissue repair product, ArtiFascia, is a multilayer, Dural repair graft made of biocompatible and bioabsorbable polymers with integrated barrier layer and a biomimetic structure of electrospun fibers designed to promote neodura regeneration. ArtiFascia is available for commercial use in the USA and has FDA 510(k) clearance.
Funding history · 9 rounds · $43.6M total
Q&A
- What is Nurami Medical's primary focus?
- Nurami Medical specializes in modernizing soft tissue surgical repair using nanofibers and novel biomaterials, aiming to create bio surgical implants that effectively seal and heal wounds.
- What is Nurami Medical's flagship product?
- Nurami Medical's first soft-tissue repair product is ArtiFascia, a multilayer Dural repair graft made of biocompatible and bioabsorbable polymers. It has FDA 510(k) clearance and is commercially available in the USA.
- When was Nurami Medical founded?
- Nurami Medical was founded in April 2014.
- How many employees does Nurami Medical have?
- Nurami Medical has 11-50 employees.
- What was Nurami Medical's most recent funding round?
- In March 2025, Nurami Medical secured $30,000,000 in a funding round with participation from.
- Which investors participated in Nurami Medical's November 2020 funding round?
- In November 2020, Nurami Medical raised $6,000,000 with Almeda Ventures and GlenRock Group participating.
- What is Nurami Medical's current funding stage?
- Nurami Medical is currently in its Series B funding stage.
- Who are the co-founders of Nurami Medical?
- The co-founders of Nurami Medical are Amir Bahar, who serves as COO & Clinical Director, and Nora Nseir, who is the Inventor, BOD, and R&D Director.
- What is the total amount of funding Nurami Medical has raised to date?
- Nurami Medical has raised a total of $43,645,000 to date.
Team · 2
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | nurami-medical.com |
|---|---|
| linkedin.com/company/5222266 | |
| facebook.com/Nurami-Medical-111635057259570 |
Identifiers & details
| Founded | 2014-4 |
|---|---|
| Employees (exact) | 28 |
Radar intelligence
Patents
| EPO | 4 |
|---|
Web history (Wayback)
| Domain | nurami-medical.com |
|---|